Please Wait.....
Report
Precision Psychiatry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Biomarkers (Genetic v/s Protein), By Sample (Blood Based v/s Non-Blood-Based), By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others), By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others), By End User (Hospital & Clinics, Academic & Research Institutions, Others), By Company and By Region
Market Report I 2022-11-01 I 115 Pages I TechSci Research
The global precision psychiatry market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rise in incidences of mental health and technological advancements, which are bolstering the market growth, globally. Precision psychiatry is new field within precision medicine, which seeks to detect and capitalize on individual differences in biology, environment, lifestyle, and social determinants of health to improve mental health prevention, diagnosis, and treatment. The other factors supporting the market's growth are increasing awareness, growing investments, increase in population, changing lifestyle, decreasing cost of sequencing, increasing adoption of inorganic growth strategies and support from governments for healthcare infrastructure. Also, the high adoption of advanced molecular diagnostic technologies by the researchers to conduct genomic and proteomic analysis associated to the onset and manifestation of psychiatric illnesses are some of the key factors that are projected to bolster the market growth.
Increase in Prevalence of Mental Disorders
Over the past few years, rise in number of people suffering from mild or severe depressive disorders is seen. These mental illness or disorders are basically caused due to chemical, genetic, and anatomical conditions, or psychological origins such as trauma. Thus, to seek better lives for those suffering from mental illness, precision psychiatry is much required, which attributes to the growth of the market, globally. For instance, according to the National Institute of Mental Health, around one in every five U.S. adults suffer from mental illness. Also, in 2020, 25.8% of females were suffering from mental illness.
Increasing Adoption of Inorganic Growth Strategies
Increasing inorganic growth strategies by key players are expected to drive the global precision psychiatry market growth during the forecast period. For instance, in 2021, Alto Neuroscience announced its emergence from stealth with $40 million in funding to advance the largest clinical-stage pipeline of precision psychiatry medicines. Similarly, in 2021, Atai Life Sciences, a biotech company in the psychedelics space, announced the formation of a new subsidiary, called PsyProtix, which is a precision psychiatry company.
Increased demand for Genomics as precision psychiatry
From past few years, genomic technologies have advanced the understanding of neuropsychiatric disorders. Genomics plays a significant part in the diagnosis of several genetic disorders. It has ample scope in precision psychiatry as it can advocate medical management constructed on the genetic face of a person with the help of clinical data and AI. It incorporates DNA sequencing methods, recombinant DNA, and bioinformatics for sequencing, assembling, and analyzing the structure and functions of genomes. Many severe mental illnesses, such as schizophrenia and bipolar disorder, are highly inherited, and have a complex pattern of inheritance. These diseases can be identified by using sequencing technology, which evaluates the rare genetic variants. With the use of sequencing technology, psychiatry can ultimately reshape by predicting disease risk and lead to better understanding of aetiology, prognosis, or treatment response. Moreover, the decrease in cost of sequencing is also a key factor to increase the growth of the market.
Market Segmentation
The global precision psychiatry market is segmented into biomarkers, sample, technology, application, end user, and company. Based on biomarker, the market is divided into genetic and protein. Based on sample, the market is divided into blood-based and non-blood-based. Based on non-blood-based, the market is further divided into saliva, urine, cerebral spinal fluid, and others. Based on technology, the market is divided into sequencing, polymerase chain reaction, microarray, immunoassay, and others. Based on application, the market is divided into Alzheimer's disease, Parkinson's disease, autism, depression, and others. Based on end user, the market is divided into hospital & clinics, academic & research institutions, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rise in incidences of mental illness in the country.
Market Players
Altimate Healthcare, PsyProtix, Inc, Cerebral-Alto Nanoscience, Precision Psychiatric Services, Inc, Tempus Labs, Inc., and Curis AI Inc. are some of the leading companies operating in the market.
Report Scope:
In this report, global precision psychiatry market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Precision Psychiatry Market, By Biomarker:
o Genetic
o Protein
- Precision Psychiatry Market, By Sample:
o Blood Based
o Non-Blood-Based
- Saliva
- Urine
- Cerebral Spinal Fluid
- Others
- Precision Psychiatry Market, By Technology:
o Sequencing
o Polymerase Chain Reaction
o Microarray
o Immunoassay
o Others
- Precision Psychiatry Market, By Application:
o Alzheimer's Disease
o Parkinson's Disease
o Autism
o Depression
o Others
- Precision Psychiatry Market, By End User:
o Hospital & Clinics
o Academic & Research Institutions
o Others
- Precision Psychiatry Market, By Region:
o North America
- United States
- Canada
- Mexico
o Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
o Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
o South America
- Brazil
- Argentina
- Colombia
o Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in precision psychiatry market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global Precision Psychiatry Market
5. Voice of Customer
6. Global Precision Psychiatry Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Biomarkers (Genetic v/s Protein)
6.2.2. By Sample (Blood Based v/s Non-Blood-Based)
6.2.2.1. By Non-Blood-Based (Saliva, Urine, Cerebral Spinal Fluid, Others)
6.2.3. By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others)
6.2.4. By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others)
6.2.5. By End User (Hospital & Clinics, Academic & Research Institutions, Others)
6.2.6. By Company (2021)
6.2.7. By Region
6.3. Product Market Map
7. North America Precision Psychiatry Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Biomarkers (Genetic v/s Protein)
7.2.2. By Sample (Blood Based v/s Non-Blood-Based)
7.2.2.1. By Non-Blood-Based (Saliva, Urine, Cerebral Spinal Fluid, Others)
7.2.3. By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others)
7.2.4. By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others)
7.2.5. By End User (Hospital & Clinics, Academic & Research Institutions, Others)
7.2.6. By Country
7.3. North America: Country Analysis
7.3.1. United States Precision Psychiatry Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Biomarker
7.3.1.2.2. By Sample
7.3.1.2.3. By Technology
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. Mexico Precision Psychiatry Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Biomarker
7.3.2.2.2. By Sample
7.3.2.2.3. By Technology
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. Canada Precision Psychiatry Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Biomarker
7.3.3.2.2. By Sample
7.3.3.2.3. By Technology
7.3.3.2.4. By Application
7.3.3.2.5. By End User
8. Europe Precision Psychiatry Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Biomarkers (Genetic v/s Protein)
8.2.2. By Sample (Blood Based v/s Non-Blood-Based)
8.2.2.1. By Non-Blood-Based (Saliva, Urine, Cerebral Spinal Fluid, Others)
8.2.3. By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others)
8.2.4. By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others)
8.2.5. By End User (Hospital & Clinics, Academic & Research Institutions, Others)
8.2.6. By Country
8.3. Europe: Country Analysis
8.3.1. France Precision Psychiatry Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Biomarker
8.3.1.2.2. By Sample
8.3.1.2.3. By Technology
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. Germany Precision Psychiatry Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Biomarker
8.3.2.2.2. By Sample
8.3.2.2.3. By Technology
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. United Kingdom Precision Psychiatry Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Biomarker
8.3.3.2.2. By Sample
8.3.3.2.3. By Technology
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. Italy Precision Psychiatry Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Biomarker
8.3.4.2.2. By Sample
8.3.4.2.3. By Technology
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Spain Precision Psychiatry Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Biomarker
8.3.5.2.2. By Sample
8.3.5.2.3. By Technology
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. Asia-Pacific Precision Psychiatry Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Biomarkers (Genetic v/s Protein)
9.2.2. By Sample (Blood Based v/s Non-Blood-Based)
9.2.2.1. By Non-Blood-Based (Saliva, Urine, Cerebral Spinal Fluid, Others)
9.2.3. By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others)
9.2.4. By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others)
9.2.5. By End User (Hospital & Clinics, Academic & Research Institutions, Others)
9.2.6. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Precision Psychiatry Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Biomarker
9.3.1.2.2. By Sample
9.3.1.2.3. By Technology
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. India Precision Psychiatry Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Biomarker
9.3.2.2.2. By Sample
9.3.2.2.3. By Technology
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. South Korea Precision Psychiatry Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Biomarker
9.3.3.2.2. By Sample
9.3.3.2.3. By Technology
9.3.3.2.4. By Application
9.3.3.2.5. By End User
9.3.4. Japan Precision Psychiatry Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Biomarker
9.3.4.2.2. By Sample
9.3.4.2.3. By Technology
9.3.4.2.4. By Application
9.3.4.2.5. By End User
9.3.5. Australia Precision Psychiatry Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Biomarker
9.3.5.2.2. By Sample
9.3.5.2.3. By Technology
9.3.5.2.4. By Application
9.3.5.2.5. By End User
10. South America Precision Psychiatry Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Biomarkers (Genetic v/s Protein)
10.2.2. By Sample (Blood Based v/s Non-Blood-Based)
10.2.2.1. By Non-Blood-Based (Saliva, Urine, Cerebral Spinal Fluid, Others)
10.2.3. By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others)
10.2.4. By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others)
10.2.5. By End User (Hospital & Clinics, Academic & Research Institutions, Others)
10.2.6. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Precision Psychiatry Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Biomarker
10.3.1.2.2. By Sample
10.3.1.2.3. By Technology
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Argentina Precision Psychiatry Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Biomarker
10.3.2.2.2. By Sample
10.3.2.2.3. By Technology
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. Colombia Precision Psychiatry Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Biomarker
10.3.3.2.2. By Sample
10.3.3.2.3. By Technology
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Middle East and Africa Precision Psychiatry Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Biomarkers (Genetic v/s Protein)
11.2.2. By Sample (Blood Based v/s Non-Blood-Based)
11.2.2.1. By Non-Blood-Based (Saliva, Urine, Cerebral Spinal Fluid, Others)
11.2.3. By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Immunoassay, Others)
11.2.4. By Application (Alzheimer's Disease, Parkinson's Disease, Autism, Depression, Others)
11.2.5. By End User (Hospital & Clinics, Academic & Research Institutions, Others)
11.2.6. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Precision Psychiatry Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Biomarker
11.3.1.2.2. By Sample
11.3.1.2.3. By Technology
11.3.1.2.4. By Application
11.3.1.2.5. By End User
11.3.2. Saudi Arabia Precision Psychiatry Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Biomarker
11.3.2.2.2. By Sample
11.3.2.2.3. By Technology
11.3.2.2.4. By Application
11.3.2.2.5. By End User
11.3.3. UAE Precision Psychiatry Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Biomarker
11.3.3.2.2. By Sample
11.3.3.2.3. By Technology
11.3.3.2.4. By Application
11.3.3.2.5. By End User
11.3.4. Egypt Precision Psychiatry Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Biomarker
11.3.4.2.2. By Sample
11.3.4.2.3. By Technology
11.3.4.2.4. By Application
11.3.4.2.5. By End User
11.3.5. Turkey Precision Psychiatry Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Biomarker
11.3.5.2.2. By Sample
11.3.5.2.3. By Technology
11.3.5.2.4. By Application
11.3.5.2.5. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Altimate Healthcare
14.2. PsyProtix, Inc
14.3. Cerebral-Alto Nanoscience
14.4. Precision Psychiatric Services, Inc
14.5. Tempus Labs, Inc.
14.6. Curis AI Inc.
15. Strategic Recommendations
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security